India has world-scale formulation capability, yet the chemistry beneath that success remains deeply concentrated in external supply chains. Official data shows China supplies 73.7% of India's imports across 200 critical API and drug intermediate categories.
Manufacturing capability is not the same as scientific capability.
In the newly released MedicinMan Intelligence Report (October 2026), we dive into the Indian pharma innovation gap. The report explores:
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
